Envarsus
Showing 1 - 25 of 59
Liver Transplant Rejection, Immune System Suppression Trial (Prograf, Envarsus)
Not yet recruiting
- Liver Transplant Rejection
- Immune System Suppression
- Prograf
- Envarsus
- (no location specified)
Dec 8, 2022
Renal Transplant Patients Trial in Aurora (Envarsus XR)
Completed
- Renal Transplant Patients
- Envarsus XR
-
Aurora, ColoradoLisa Kornfeld
May 10, 2022
Neurotoxicity, Liver Transplant; Complications Trial in Charleston (Envarsus, Tacrolimus Immediate release)
Active, not recruiting
- Neurotoxicity
- Liver Transplant; Complications
- Envarsus
- Tacrolimus Immediate release
-
Charleston, South CarolinaMedical University of South Carolina
Apr 20, 2022
Renal Transplant Failure Trial in London (Envarsus, Adoport)
Withdrawn
- Renal Transplant Failure
- Envarsus
- Adoport
-
London, United KingdomBarts Health NHS Trust
Mar 21, 2022
End Stage Renal Disease Trial in Lexington (Tacrolimus, Envarsus XR)
Recruiting
- End Stage Renal Disease
- Tacrolimus
- Envarsus XR
-
Lexington, KentuckyUniversity of Kentucky Transplant Center
Mar 11, 2022
Kidney Transplant Recipients Trial in Phoenix, Jacksonville, Rochester (Envarsus XR, Tacrolimus twice daily)
Active, not recruiting
- Kidney Transplant Recipients
- Envarsus XR
- Tacrolimus twice daily
-
Phoenix, Arizona
- +2 more
Jan 4, 2022
Lung Transplant; Complications Trial in Nashville (Tacrolimus Extended Release Oral Tablet [Envarsus], Tacrolimus, Mycophenolate
Not yet recruiting
- Lung Transplant; Complications
- Tacrolimus Extended Release Oral Tablet [Envarsus]
- +4 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jun 6, 2022
Prophylaxis Against Liver Transplant Rejection Trial in Germany (Tacrolimus Pill, Tacrolimus capsule)
Recruiting
- Prophylaxis Against Liver Transplant Rejection
- Tacrolimus Pill
- Tacrolimus capsule
-
Aachen, Germany
- +14 more
May 16, 2022
Renal Transplant Trial in Nashville (Change from Prograf to Envarsus XR)
Recruiting
- Renal Transplant
- Change from Prograf to Envarsus XR
-
Nashville, TennesseeVUMC
Jul 8, 2021
Kidney Transplantation, Pancreas Transplantation, Diabetes Trial in Nantes (Tacrolimus and Tacrolimus Extended Release Oral
Recruiting
- Kidney Transplantation
- +2 more
- Tacrolimus and Tacrolimus Extended Release Oral Tablet [Envarsus]
-
Nantes, FranceNantes University Hospital
Aug 10, 2022
Kidney Transplant Rejection Trial in Los Angeles (Extended-release tacrolimus, Immediate-release tacrolimus)
Recruiting
- Kidney Transplant Rejection
- Extended-release tacrolimus
- Immediate-release tacrolimus
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jan 18, 2022
Liver Transplant; Complications, Renal Insufficiency, Immunosuppressant Adverse Reaction Trial in Edmonton (Envarsus Oral
Suspended
- Liver Transplant; Complications
- +4 more
- Envarsus Oral Product
- Prograf (SOC)
-
Edmonton, Alberta, CanadaUniverity of Alberta
Jul 7, 2022
End Stage Renal Disease, Rejection of Renal Transplant Trial in Chicago (Tacrolimus, Tacrolimus Extended Release Oral Tablet
Completed
- End Stage Renal Disease
- Rejection of Renal Transplant
- Tacrolimus
- Tacrolimus Extended Release Oral Tablet [Envarsus]
-
Chicago, IllinoisNorthwestern University
Jan 12, 2023
" SAVE Study for Fast Metabolizers Kidney Transplant Recipients"
Recruiting
- Renal Transplant Failure
- No intervention
-
Nantes, FranceCHU de Nantes
Jul 29, 2021
Graft-versus-host Disease Trial in Milwaukee (Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil)
Not yet recruiting
- Graft-versus-host Disease
- Cyclophosphamide
- +3 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Jan 26, 2023
Posttransplant Diabetes Trial in Tuebingen (LCP-tacrolimus, twice-daily tacrolimus)
Recruiting
- Posttransplant Diabetes Mellitus
- LCP-tacrolimus
- twice-daily tacrolimus
-
Tuebingen, GermanyUniversity Hospital Tuebingen
Jun 21, 2022
Liver Transplantation Trial in Hamburg (Treatment 2 weeks Envarsus followed by 2 weeks Advagraf, Treatment 2 weeks Advagraf
Completed
- Liver Transplantation
- Treatment 2 weeks Envarsus followed by 2 weeks Advagraf
- Treatment 2 weeks Advagraf followed by 2 weeks Envarsus
-
Hamburg, GermanyUniversity Hospital Hamburg-Eppendorf
May 3, 2021
Alterations in Cognitive Function and Cerebral Blood Flow After
Completed
- End Stage Renal Disease
- Envarsus
- Tacrolimus
-
Kansas City, KansasUniversity of Kansas Medical Center
Apr 26, 2021
Kidney Transplant Failure and Rejection Trial in Minneapolis (immediate-release tacrolimus, extended release tacrolimus)
Completed
- Kidney Transplant Failure and Rejection
- immediate-release tacrolimus
- extended release tacrolimus
-
Minneapolis, MinnesotaUniversity of Minnesota
Mar 22, 2021
Kidney Transplant; Complications, Toxicity, Drug Toxicity Trial in Sacramento (Envarsus, IR Tacrolimus)
Recruiting
- Kidney Transplant; Complications
- +3 more
- Envarsus
- IR Tacrolimus
-
Sacramento, CaliforniaUC Davis
Jan 25, 2022
Recipients of Liver Transplant Trial in Memphis (Envarsus XR, Prograf)
Completed
- Recipients of Liver Transplant
- Envarsus XR
- Prograf
-
Memphis, TennesseeMethodist Healthcare, University Hospital
Jan 11, 2021
Kidney Transplantation, Kidney Transplant Rejection Trial in Los Angeles (Twice-daily Tacrolimus, Once-daily envarsus XR,
Recruiting
- Kidney Transplantation
- Kidney Transplant Rejection
- Twice-daily Tacrolimus
- +5 more
-
Los Angeles, CaliforniaUniversity of Southern California
Jun 6, 2022
Liver Transplantation, Immunosuppression, Neurotoxicity Trial (Tacrolimus, Immediate Release, Oral, Tacrolimus Extended Release
Not yet recruiting
- Liver Transplantation
- +4 more
- Tacrolimus, Immediate Release, Oral
- Tacrolimus Extended Release Oral Tablet
- (no location specified)
Oct 20, 2021
Kidney Transplant Trial in Philadelphia (Tacrolimus Extended Release Oral Tablet [Envarsus] 0.13mg/kg/day initiated within
Completed
- Kidney Transplant
- Tacrolimus Extended Release Oral Tablet [Envarsus] 0.13mg/kg/day initiated within post-operative day 3 after kidney transplant
-
Philadelphia, PennsylvaniaTemple University Hospital
Feb 10, 2022